Cantourage Group SE (XTRA: HIGH)
Health Care · Pharmaceuticals · DE
€5.18
-1.15% today · +42.0% 1Y
Cantourage Group SE (XTRA: HIGH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $73.54M.
Over the last twelve months the share price has gained 42.0%, trading between 2.32 and 6.86.
Tweenvest scores Cantourage Group SE across four factors: quality 72/100, value 50/100. Its strongest factor is quality.
HIGH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $73.54M
- Revenue (TTM)
- $4.59M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- -0.00
- 52-week high
- €6.86
- 52-week low
- €2.32
- Avg volume (3M)
- —
- Shares outstanding
- 12.47M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Verrica Pharmaceuticals Inc.NasdaqCM: VRCA | $75.24M | $4.18 | -4.57% |
| Protect Animal Health Inc.TPEX: 7850 | $74.65M | NT$24.35 | +37.18% |
| NeOnc Technologies Holdings, Inc.NasdaqGM: NTHI | $74.32M | $2.53 | -15.38% |
| Vetnostrum Animal Health Co., Ltd.TWSE: 6936 | $73.59M | NT$32.20 | +1.58% |
| Domesco Medical Import - Export Joint-Stock CorporationHOSE: DMC | $73.24M | ₫54,800.00 | -5.52% |
| Poolbeg Pharma PLCAIM: POLB | $72.52M | £0.07 | -3.90% |
| Charlotte's Web Holdings, Inc.TSX: CWEB | $72.32M | CA$0.37 | -3.95% |
| Wanbury LimitedBSE: 524212 | $72.22M | Rs199.00 | -11.16% |
Figures last refreshed Oct 4, 2026.